Nitric oxide and superoxide anion production in monocytes from children exposed to arsenic and lead in region Lagunera, Mexico

Toxicology and Applied Pharmacology

Volumn 198, Issue 3, 2004, Pages 283-290

  Pineda Zavaleta, Ana Patricia ^a   García Vargas, Gonzalo ^b   Borja Aburto, Victor H ^a,c   Acosta Saavedra, Leonor C ^a   Vera Aguilar, Eunice ^a   Gómez Muñoz, Arístides ^a   Cebrián, Mariano E ^a   Calderón Aranda, Emma S ^a,d  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Arsenic; Children; Immunotoxicity; Lead; Nitric oxide; Superoxide

Indexed keywords

ARSENIC; GAMMA INTERFERON; LEAD; LIPOPOLYSACCHARIDE; NITRIC OXIDE; SUPEROXIDE;

ARSENIC POISONING; ARTICLE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; DRUG URINE LEVEL; DUST EXPOSURE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOREGULATION; LEAD BLOOD LEVEL; LEAD POISONING; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIVARIATE ANALYSIS; SEX RATIO; SMELTER; SOIL POLLUTION; TH1 CELL;

ARSENIC; CHILD; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; INTERFERON TYPE II; LEAD; LIPOPOLYSACCHARIDES; MALE; MEXICO; MONOCYTES; NITRIC OXIDE; SUPEROXIDES;

EID: 3242816233     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.taap.2003.10.034     Document Type: Article

References (51)

1. Applegate L.A., Luscher P., Tyrrell R.M. Induction of heme oxygenase: a general response to oxidant stress in cultured mammalian cells. Cancer Res. 51:1991;974-978
2. ATSDR Toxicological profile for Lead. Agency for Toxic Substances Disease Registry. 1999;U.S. Department of Health and Human Services, Atlanta, GA
3. Barchowsky A., Klei L., Dudek E.J., Swartz H.M., James P.E. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic. Biol. Med. 27:1999;1405-1412
4. Benin A.L., Sargent J.D., Dalton M., Roda S. High concentrations of heavy metals in neighborhoods near ore smelters in Northern Mexico. Environ. Health Perspect. 107:1999;279-284
5. Borella P., Giardino A. Lead and Cadmium at very low dose affect in vitro immune response of human lymphocytes. Environ. Res. 55:1991;165-177
6. Bradford M.M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the Principle-Dye Binding. Anal. Biochem. 72:1976;248-254
7. Bunn T.L., Parsons P.J., Kao E., Dietert R.R. Exposure to lead during critical windows of embryonic development: differential immunotoxic outcome based on stage of exposure and gender. Toxicol. Sci. 64:2001;57-66
8. Burns L.A., Munson A.E. Gallium arsenide selectively inhibits T cell proliferation and alters expression of CD25(IL-2R/p55). J. Pharmacol. Exp. Ther. 265:1993;178-186
9. Burns L.A., Sikorski E.E., Saady J., Munson A.E. Evidence for arsenic as the primary immunosuppressive component of gallium arsenide. Toxicol. Appl. Pharmacol. 110:1991;157-169
10. Bustamante J., Dock L., Vahter M., Fowler B., Orrenius S. The semiconductor elements arsenic and indium induce apoptosis in rat thymocytes. Toxicology. 118:1997;129-136
11. Castillo A., Rodríguez T. Influencia de la exposición ocupacional al plomo sobre la concentración de inmunoglobulinas y la función celular inmune en el hombre. Rev. Alerg. 40(4):1993;95-97
12. CDC (Centers for Disease Control) Preventing Lead Poisoning in Young Children: A Statement by the Centers for Disease Control - October 1991. 1991;U.S. Department of Health and Human Services, Atlanta, GA
13. Cebrian M.E., Albores A., Garcia-Vargas G., Del Razo L.M., Ostrosky-Wegman P. Chronic arsenic poisoning in humans: the case of Mexico. Nriagu J. Arsenic in the Environment, Part II: Human Health and Ecosystem Effects. 1994;93-107 Wiley, New York
14. Chattopadhyay S., Bhaumik S., Purkayastha M., Basu S., Nag-Chaudhuri A., Das-Gupta S. Apoptosis and necrosis in developing brain cells due to arsenic toxicity and protection with antioxidants. Toxicol. Lett. 136:2002;65-76
15. Cooney R.V., Harwood P.J. Effects of arsenic compounds on proliferation and nitric oxide synthesis in C3H 10T 1/2 murine fibroblasts. Appl. Organometal. Chem. 11:1997;397-402
16. Cox D.H. Arsine evolution-electrothermal atomic absorption method for the determination of nanogram levels of total arsenic in urine and water. J. Anal Toxicol. 4:1980;207-211
17. Del Razo L.M., Garcia-Vargas G.G., Vargas H., Albores A., Gonsebatt M.E., Montero R., Ostrosky-Wegman P., Kelsh M., Cebrian M.E. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. Arch. Toxicol. 71:1997;211-217
18. Fischbein A., Tsang P., Luo J., Bekesi J.G. The immune system as target for subclinical Pb related toxicity. Br. J. Ind. Med. 50:1993;185-186
19. Flora S.J.S. Arsenic-induced oxidative stress and its reversibility following combined administration of N-acetylcysteine and meso 2,3-dimercaptosuccinic acid in rats. Clin. Exp. Pharmacol. Physiol. 26:1999;865-869
20. Fuente H.D., Portales-Perez D., Baranda L., Diaz-Barriga F., Saavedra-Alanis V., Layseca E., Gonzales-Amaro R. Effect of arsenic, cadmium and lead on the induction of apoptosis of normal human mononuclear cells. Clin. Exp. Immunol. 129:2002;69-77
21. García-Vargas G.G., Rubio-Andrade M., Del Razo L.M., Borja-Aburto V., Vera-Aguilar E., Cebrián M.E. Lead exposure in children living in a smelter community in Region Lagunera, Mexico. J. Toxicol. Environ. Health, Part A. 62:2001;417-429
22. 15N]-nitrite in biological fluids. Anal. Biochem. 126:1982;131-138
23. Governa M., Valentino M., Visona I. In vitro impairment of human granulocyte functions by Pb. Arch. Toxicol. 59:1987;421-425
24. Goytia-Acevedo R.C., Cebrian M.E., Calderon-Aranda E.S. Differential effects of arsenic on intracellular free calcium levels and the proliferative response of murine mitogen-stimulated lymphocytes. Toxicology. 189:2003;235-244
25. Heo Y., Parsons P., Lawrence D. Lead differentially modifies cytokine production in vitro and in vivo. Toxicol. Appl. Pharmacol. 138:1996;149-157
26. Heo Y., Lee W., Lawrence D. Differential effects of Pb and cAMP on development and activities of Th1- and Th2-lymphocytes. Toxicol. Sci. 43:1998;172-185
27. Hossain K., Akhand A.A., Kato M., Du J., Takeda K., Wu J., Takeuchi K., Liu W., Suzuki H., Nakashima I. Arsenite induces apoptosis of murine T lymphocytes through membrane raft-linked signaling for activation of c-jun amino-terminal kinase. J. Immunol. 165:2000;4290-4297
28. Kao Y.H., Yu C.L., Chang L.W., Yu H.S. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem. Res. Toxicol. 16:2003;460-468
29. Kishikawa H., Song R., Lawrence D. Interleukin-12 promotes enhanced resistance to Listeria monocytogenes infection of Pb-exposed mice. Toxicol. Appl. Pharmacol. 147:1997;180-189
30. Krocova Z., Macela A., Kroca M., Hernychova L. The immunomodulatory effect(s) of lead and cadmium on the cells of immune system in vitro. Toxicol. In Vitro. 14:2000;33-40
31. Lantz R.C., Parliman G., Chen G.J., Barber D., Winski S., Carter D.E. Effect of arsenic exposure on alveolar macrophage function: II. Effect of slightly soluble forms of As(III) and As(V). Environ. Res. 68:1995;59-67
32. Lee J., Battles A. Lead toxicity via arachidonate signal transduction to growth responses in the splenic macrophage. Environ. Res. 67:1994;209-219
33. Lee T.C., Jan K.Y., Wang T.C. Modulation of cellular antioxidant defense activities by sodium arsenite in human fibroblast. Arch. Toxicol. 69:1995;498-504
34. Lutz P.M., Wilson T.J., Ireland J., Jones A.L., Gorman J.S., Gale N.L., Johnson J.C., Hewett J.E. Elevated immunoglobulin E (IgE) levels in children with exposure to environmental lead. Toxicology. 134:1999;63-78
35. Miller T., Golemboski K., Ha R., Bunn T., Sanders F., Dietert R. Developmental exposure to Pb causes persistent immunotoxicity in Fischer 344 rats. Toxicol. Sci. 42:1998;129-135
36. Ostrosky-Wegman P., Gonsebatt M.E., Montero R. Lymphocyte proliferation kinetics and genotoxic findings in a pilot study on individuals chronically exposed to arsenic in Mexico. Mutat. Res. 250:1991;447-482
37. Petres J., Baron D., Hagerdon M. Effects of arsenic on cell metabolism and cell proliferation: cytogenetic and biochemical studies. Environ. Health Perspect. 19:1977;223-227
38. Pi J.B., Kumagai Y., Sun G.F., Yamauchi H., Yoshida T., Iso H., Endo A., Yu L.Y., Yuki K., Miyauchi T., Shimojo N. Decreased serum concentrations of nitric oxide metabolites among Chinese in an endemic area of chronic arsenic poisoning in Inner Mongolia. Free Radic. Biol. Med. 28:2000;1137-1142
39. Pi J.B., Kamagai Y., Yamauchi H., Nikaido M., Horikuchi S., Sun Y., Li S., Sun G.F., Shimojo N. A possible mechanism for nitric oxide dysfunction induced by prolonged arsenic exposure (Abstract). Presented at the China Fluoride and Arsenic Society 2nd Conference on Fluoride and Arsenic Research, 2-5 June 2001, Yuncheng, Shanxi, China:2001
40. Pi J.B., Yamauchi H., Kumagai Y., Sun G.F., Yoshida T., Aikawa H., Hopenhayn-Rich C., Shimojo N. Evidence for induction of oxidative stress caused by chronic exposure of Chinese residents to arsenic contained in drinking water. Environ. Health Perspect. 110:2002;331-336
41. Pick E., Mizel D. Rapid microassay for the measurement of superoxide and hydrogen peroxide by cells in culture using an automatic enzyme immunoassay reader. J. Immunol. Methods. 46:1981;211-214
42. Queiroz M.L., Almeida M. Defective neutrophil function in workers occupationally exposed to Pb. Pharmacol. Toxicol. 72:1993;73-77
43. Ramos O., Carrizales L., Yánez L., Mejía J., Batres L., Ortiz D., Díaz-Barriga F. Arsenic increased lipid peroxidation in rat tissues by a mechanism independent of glutathione levels. Environ. Health Perspect. 103:1995;85-88
44. Sengupta M., Bishay B. Effect of lead and arsenic on murine macrophage response. Drug Chem. Toxicol. 25:2002;459-472
45. Sikorski E.E., Burns L.A., Stern M.L., Luster M.I., Munson A.E. Splenic cell targets in gallium arsenide-induced suppression of the primary antibody response. Toxicol. Appl. Pharmacol. 110:1991;129-142
46. Tian L., Lawrence D.A. Lead inhibits nitric oxide production in vitro by murine splenic macrophages. Toxicol. Appl. Pharmacol. 132:1995;156-163
47. Vaziri N., Ding Y. Effect of lead on nitric oxide synthase expression in coronary endothelial cells. Role of superoxide. Hypertension. 37:2001;223-226
48. Wijeweera J.B., Gandolfi A.J., Parrish A., Lantz R.C. Sodium arsenite enhances AP-1 and NFκB DNA binding and induces stress protein expression in precision-cut rat lung slices. Toxicol. Sci. 612:2001;283-294
49. Yu H.S., Chang K.L., Yu C.L., Wu C.S., Chen G.S., Jo J.C. Defective IL-2 receptor expression in lymphocytes of patients with arsenic-induced Bowen's disease. Arch. Dermatol. Res. 290:1998;681-687
50. Yücesoy B., Turhan A., Üre M., Imir T., Karakaya A. Effects of occupational Pb and cadmium exposure on some immunoregulatory cytokine levels in man. Toxicology. 123:1997;143-147
51. Zelikoff J.T., Parson E., Schlesinger R.B. Inhalation of particulate lead oxide disrupts pulmonary macrophage-mediated functions important for host defense and tumor surveillance in the lung. Environ. Res. 62:1993;207-222